Cargando…

Bacteriophages as Solid Tumor Theragnostic Agents

Cancer, especially the solid tumor sub-set, poses considerable challenges to modern medicine owing to the unique physiological characteristics and substantial variations in each tumor’s microenvironmental niche fingerprints. Though there are many treatment methods available to treat solid tumors, st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veeranarayanan, Srivani, Azam, Aa Haeruman, Kiga, Kotaro, Watanabe, Shinya, Cui, Longzhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745063/ https://www.ncbi.nlm.nih.gov/pubmed/35008840 http://dx.doi.org/10.3390/ijms23010402

Ejemplares similares

Bacteriophage Technology and Modern Medicine
por: Azam, Aa Haeruman, et al.
Publicado: (2021)

Bacteriophage Bioengineering: A Transformative Approach for Targeted Drug Discovery and Beyond
por: Cui, Longzhu, et al.
Publicado: (2023)

The Association Between Onset of Staphylococcal Non-menstrual Toxic Shock Syndrome With Inducibility of Toxic Shock Syndrome Toxin-1 Production
por: Taki, Yusuke, et al.
Publicado: (2022)

Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA)
por: Thitiananpakorn, Kanate, et al.
Publicado: (2020)

Composition and Diversity of CRISPR-Cas13a Systems in the Genus Leptotrichia
por: Watanabe, Shinya, et al.
Publicado: (2019)

Corrigendum: Composition and Diversity of CRISPR-Cas13a Systems in the Genus Leptotrichia
por: Watanabe, Shinya, et al.
Publicado: (2020)

Complete Genome Sequence of a Panton-Valentine Leukocidin-Negative Staphylococcus aureus Strain Isolated from a Patient with Pervasive Necrotizing Soft Tissue Infection
por: Aiba, Yoshifumi, et al.
Publicado: (2020)

Identification and characterization of mutations responsible for the β-lactam resistance in oxacillin-susceptible mecA-positive Staphylococcus aureus
por: Boonsiri, Tanit, et al.
Publicado: (2020)

Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria
por: Kiga, Kotaro, et al.
Publicado: (2020)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
por: Cimini, Andrea, et al.
Publicado: (2020)

Targeting Copper in Cancer Imaging and Therapy: A New Theragnostic Agent
por: Capriotti, Gabriela, et al.
Publicado: (2022)

Metal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents
por: Shabatina, Tatyana I., et al.
Publicado: (2023)

Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications
por: Uthaman, Saji, et al.
Publicado: (2018)

PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
por: Rizzo, Alessio, et al.
Publicado: (2022)

Molecular Imaging and Theragnostics of Thyroid Cancers
por: Giovanella, Luca, et al.
Publicado: (2022)

Aptamers as Theragnostic Tools in Prostate Cancer
por: Cruz-Hernández, Carlos David, et al.
Publicado: (2022)

Personalisation of Molecular Radiotherapy through Optimisation of Theragnostics
por: Davis, LauraMay, et al.
Publicado: (2020)

Nuclear Medicine and Cancer Theragnostics: Basic Concepts
por: Zoi, Vasiliki, et al.
Publicado: (2023)

Clinical Feasibility Study of Gold Nanoparticles as Theragnostic Agents for Precision Radiotherapy
por: López-Valverde, José Antonio, et al.
Publicado: (2022)

Complete genome sequencing of three human clinical isolates of Staphylococcus caprae reveals virulence factors similar to those of S. epidermidis and S. capitis
por: Watanabe, Shinya, et al.
Publicado: (2018)

What Is Known about Theragnostic Strategies in Colorectal Cancer
por: Parisi, Alessandro, et al.
Publicado: (2021)

Theragnostic potentials of core/shell mesoporous silica nanostructures
por: Ravindran Girija, Aswathy, et al.
Publicado: (2019)

Metabolic Priming as a Tool in Redox and Mitochondrial Theragnostics
por: Pinho, Sónia A., et al.
Publicado: (2023)

Fluorescence/photoacoustic imaging-guided nanomaterials for highly efficient cancer theragnostic agent
por: Doan, Vu Hoang Minh, et al.
Publicado: (2021)

Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents
por: Hishiki, Takayuki, et al.
Publicado: (2023)

Theragnostic ultrasound using microbubbles in the treatment of prostate cancer
por: Lee, Hak Jong, et al.
Publicado: (2016)

Nanomaterials as Ultrasound Theragnostic Tools for Heart Disease Treatment/Diagnosis
por: Alphandéry, Edouard
Publicado: (2022)

Glioma extracellular vesicles for precision medicine: prognostic and theragnostic application
por: Marei, Hany E., et al.
Publicado: (2022)

Shifting emphasis from pharmacogenomics to theragnostics
por: Ozdemir, Vural, et al.
Publicado: (2006)

Distribution of Extended-Spectrum β-Lactamase Genes and Antimicrobial Susceptibility among Residents in Geriatric Long-Term Care Facilities in Japan
por: Akine, Dai, et al.
Publicado: (2021)

Photo-Functionalized Magnetic Nanoparticles as a Nanocarrier of Photodynamic Anticancer Agent for Biomedical Theragnostics
por: Nam, Ki Chang, et al.
Publicado: (2020)

Theragnostic Imaging Using Radiolabeled Antibodies and Tyrosine Kinase Inhibitors
por: Yoshimoto, Mitsuyoshi, et al.
Publicado: (2015)

Molecularly imprinted polymers (MIPs): emerging biomaterials for cancer theragnostic applications
por: Kang, Min Seok, et al.
Publicado: (2023)

Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
por: Piscopo, Leandra, et al.
Publicado: (2023)

Author Correction: Fluorescence/photoacoustic imaging-guided nanomaterials for highly efficient cancer theragnostic agent
por: Doan, Vu Hoang Minh, et al.
Publicado: (2021)

Radiolabeled Anti-Adenosine Triphosphate Synthase Monoclonal Antibody as a Theragnostic Agent Targeting Angiogenesis
por: Park, Bok-Nam, et al.
Publicado: (2017)

The potential of exosomes as theragnostics in various clinical situations
por: Kang, Ju-Seop
Publicado: (2020)

Deoxyglucose-conjugated persistent luminescent nanoparticles for theragnostic application in fibrosarcoma tumor model
por: Sharma, K. S., et al.
Publicado: (2023)

The potential theragnostic (diagnostic+therapeutic) application of exosomes in diverse biomedical fields
por: Kim, Yong-Seok, et al.
Publicado: (2018)

From the Magic Bullet to Theragnostics: Certitudes and Hypotheses, Trying to Optimize the Somatostatin Model
por: Di Stasio, Giuseppe Danilo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i9kunkd6p0b3to5hk9gnocao3i